![Alan H. Auerbach - Chief Executive Officer & President @ Puma Biotechnology - Crunchbase Person Profile Alan H. Auerbach - Chief Executive Officer & President @ Puma Biotechnology - Crunchbase Person Profile](https://res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/v1498388026/lvjklczpmuxg486pm7q6.jpg)
Alan H. Auerbach - Chief Executive Officer & President @ Puma Biotechnology - Crunchbase Person Profile
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2021 Financial Results
![Puma Biotechnology: Too Little, Too Late, Too Much Of A Bad Side Effect (NASDAQ:PBYI) | Seeking Alpha Puma Biotechnology: Too Little, Too Late, Too Much Of A Bad Side Effect (NASDAQ:PBYI) | Seeking Alpha](https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1131160351/image_1131160351.jpg?io=getty-c-w1536)
Puma Biotechnology: Too Little, Too Late, Too Much Of A Bad Side Effect (NASDAQ:PBYI) | Seeking Alpha
![The Daily Biotech Pulse: IPOs, Puma's Breast Cancer Drug Gets Label Expansion, Buyout Offer For Organovo The Daily Biotech Pulse: IPOs, Puma's Breast Cancer Drug Gets Label Expansion, Buyout Offer For Organovo](https://s.yimg.com/ny/api/res/1.2/QsH6XzuE3O7AAEj6zp9p_A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTQyNw--/https://cdn1.benzinga.com/files/imagecache/600x400xUP/images/story/2012/medications-257336_1920_52.jpg)